Factors associated with medication persistence among ischemic stroke patients: a systematic review
- 22 April 2020
- journal article
- review article
- Published by Informa UK Limited in Neurological Research
- Vol. 42 (7), 537-546
- https://doi.org/10.1080/01616412.2020.1754640
Abstract
Objective: An investigation of the prevalence of medication persistence and associated factors in order to inform effective strategies for improving medication persistence. Methods: A systematic review of the literature from 2010 to the present was performed, using the PRISMA protocol. Primary and empirical observational studies of adult ischemic stroke or transient ischemic attack patients were included. PubMed, CINAHL, Web of Science, Cochrane Library, and PsycInfo databases were searched using the key terms stroke, ischemic stroke, medication persistence, medication adherence, and patient compliance. Results: Of four hundred twenty-eight journal articles retrieved, a final 18 articles were included. Short-term medication persistence was 46.2–96.7%, and long-term medication persistence was 41.7–93.0%. Identified hospital-related factors for medication persistence were stroke unit care, in-hospital medical complications, and early follow-up visit. Demographic factors for medication persistence were older age, and high/adequate financial status; disease-related factors were disease history, stroke subtype, and symptom severity. Age less than 75, female sex, comorbidity, antiplatelet medication switch, and polypharmacy were identified as factors of medication nonpersistence. Conclusions: Stroke patients’ medication persistence decreases over time, and persistence on antiplatelets, anticoagulants, and statin was poor. Several factors were associated with medication persistence, and these factors should be considered in future secondary preventative strategies.Keywords
Funding Information
- no financial support for the research
This publication has 53 references indexed in Scilit:
- Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative studyBMC Neurology, 2013
- Statin Therapy and Outcome After Ischemic StrokeStroke, 2013
- Self-Report of Stroke, Transient Ischemic Attack, or Stroke Symptoms and Risk of Future Stroke in the Reasons for Geographic And Racial Differences in Stroke (REGARDS) StudyStroke, 2013
- A new taxonomy for describing and defining adherence to medicationsBritish Journal of Clinical Pharmacology, 2012
- Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational studyPharmacoepidemiology and Drug Safety, 2011
- Secondary preventive medication persistence and adherence 1 year after strokeNeurology, 2011
- Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After StrokeStroke, 2010
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Combining Multiple Approaches for the Secondary Prevention of Vascular Events After StrokeStroke, 2007
- Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial FibrillationStroke, 2006